Hangzhou Tigermed Consulting Co., Ltd.
HNGZY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $25,166,479 | $25,794,045 | $68,601,419 | $70,325,190 |
| - Cash | $2,055,345 | $7,419,992 | $7,858,140 | $8,544,356 |
| + Debt | $2,634,984 | $2,827,026 | $2,801,313 | $1,189,457 |
| Enterprise Value | $25,746,118 | $21,201,078 | $63,544,593 | $62,970,291 |
| Revenue | $6,603,120 | $7,384,039 | $7,085,471 | $5,213,538 |
| % Growth | -10.6% | 4.2% | 35.9% | – |
| Gross Profit | $2,242,013 | $2,848,529 | $2,808,464 | $2,270,655 |
| % Margin | 34% | 38.6% | 39.6% | 43.6% |
| EBITDA | $1,129,837 | $2,846,507 | $2,953,401 | $3,894,660 |
| % Margin | 17.1% | 38.5% | 41.7% | 74.7% |
| Net Income | $405,143 | $2,024,850 | $2,006,552 | $2,874,163 |
| % Margin | 6.1% | 27.4% | 28.3% | 55.1% |
| EPS Diluted | 0.47 | 2.34 | 2.32 | 3.3 |
| % Growth | -79.9% | 0.9% | -29.7% | – |
| Operating Cash Flow | $1,097,002 | $1,150,438 | $1,357,501 | $1,423,796 |
| Capital Expenditures | -$356,554 | -$313,757 | -$448,603 | -$368,620 |
| Free Cash Flow | $740,447 | $836,681 | $908,898 | $1,055,177 |